Literature DB >> 12952416

Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor.

Joanna E Burdette1, Jianghua Liu, Shao-Nong Chen, Daniel S Fabricant, Colleen E Piersen, Eric L Barker, John M Pezzuto, Andrew Mesecar, Richard B Van Breemen, Norman R Farnsworth, Judy L Bolton.   

Abstract

Extracts of the rhizome of black cohosh [Actaea racemosa L., formerly called Cimicifuga racemosa (L.) Nutt.] were evaluated for potential mechanisms of action in the alleviation of menopausal hot flashes. Ovariectomized Sprague-Dawley rats were administered a 40% 2-propanol extract of black cohosh [4, 40, and 400 mg/(kg.day)] by gavage for 2 weeks with or without estradiol [50 microg/(kg.day)] to determine if black cohosh could act as an estrogen or antiestrogen on the basis of an increase in uterine weight or vaginal cellular cornification. No effects were observed on uterine weight or on vaginal cellular cornification in rats treated with black cohosh alone or in combination with 17beta-estradiol, indicating this black cohosh extract had no estrogenic or antiestrogenic properties in the ovariectomized rat model. To evaluate other potential pathways by which black cohosh might reduce menopausal hot flashes, serotonin activity was first assessed by the inhibition of radioligand binding to cell membrane preparations containing recombinant human serotonin receptor (5-HT) subtypes. A 40% 2-propanol extract of black cohosh was tested against 10 subtypes of the serotonin receptor, revealing the presence of compounds with strong binding to the 5-HT(1A), 5-HT(1D), and 5-HT(7) subtypes. Subsequent binding studies were carried out using 5-HT(1A) and 5-HT(7) receptors because of their association with the hypothalamus, which has been implicated in the generation of hot flashes. The black cohosh 40% 2-propanol extract inhibited [(3)H]lysergic acid diethylamide (LSD) binding to the human 5-HT(7) receptor (IC(50) = 2.4 +/- 0.4 microg/mL) with greater potency than binding of [(3)H]-8-hydroxy-2-(di-N-propylamino)tetralin to the rat 5-HT(1A) receptor (IC(50) = 13.9 +/- 0.6 microg/mL). Analysis of ligand binding data indicated that components of a black cohosh methanol extract functioned as a mixed competitive ligand of the 5-HT(7) receptor. In addition, a black cohosh methanol extract elevated cAMP levels in 293T-5-HT(7)-transfected HEK cells, suggesting the extract acted as a partial agonist at the receptor. The elevation in cAMP mediated by the black cohosh extract could be reversed in the presence of the antagonist methiothepin, indicating a receptor-mediated process. These data suggest that reductions in hot flashes in some women taking black cohosh may not be due to estrogenic properties. This study identifies other possible biological targets of black cohosh that could account for reported biological effects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12952416     DOI: 10.1021/jf034264r

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  49 in total

1.  Evaluation of the botanical authenticity and phytochemical profile of black cohosh products by high-performance liquid chromatography with selected ion monitoring liquid chromatography-mass spectrometry.

Authors:  Bei Jiang; Fredi Kronenberg; Paiboon Nuntanakorn; Ming-Hua Qiu; Edward J Kennelly
Journal:  J Agric Food Chem       Date:  2006-05-03       Impact factor: 5.279

2.  Pregnane X receptor-mediated induction of Cyp3a by black cohosh.

Authors:  Xiaoyan Pang; Jie Cheng; Kristopher W Krausz; De-an Guo; Frank J Gonzalez
Journal:  Xenobiotica       Date:  2010-10-27       Impact factor: 1.908

Review 3.  Discussion of a well-designed clinical trial which did not demonstrate effectiveness: UIC center for botanical dietary supplements research study of black cohosh and red clover.

Authors:  Lee P Shulman; Suzanne Banuvar; Harry H S Fong; Norman R Farnsworth
Journal:  Fitoterapia       Date:  2010-10-27       Impact factor: 2.882

Review 4.  The role of quality assurance and standardization in the safety of botanical dietary supplements.

Authors:  Richard B van Breemen; Harry H S Fong; Norman R Farnsworth
Journal:  Chem Res Toxicol       Date:  2007-03-16       Impact factor: 3.739

5.  In vitro serotonergic activity of black cohosh and identification of N(omega)-methylserotonin as a potential active constituent.

Authors:  Sharla L Powell; Tanja Gödecke; Dejan Nikolic; Shao-Nong Chen; Soyoun Ahn; Birgit Dietz; Norman R Farnsworth; Richard B van Breemen; David C Lankin; Guido F Pauli; Judy L Bolton
Journal:  J Agric Food Chem       Date:  2008-12-24       Impact factor: 5.279

6.  Black cohosh has central opioid activity in postmenopausal women: evidence from naloxone blockade and positron emission tomography neuroimaging.

Authors:  Nancy E Reame; Jane L Lukacs; Vasantha Padmanabhan; Aimee D Eyvazzadeh; Yolanda R Smith; Jon-Kar Zubieta
Journal:  Menopause       Date:  2008 Sep-Oct       Impact factor: 2.953

7.  Metabolism of Nω -methylserotonin, a serotonergic constituent of black cohosh (Cimicifuga racemosa, L. (Nutt.)), by human liver microsomes.

Authors:  Dejan Nikolić; Jinghu Li; Richard B van Breemen
Journal:  Biomed Chromatogr       Date:  2014-05-12       Impact factor: 1.902

8.  Phytochemistry of cimicifugic acids and associated bases in Cimicifuga racemosa root extracts.

Authors:  Tanja Gödecke; Dejan Nikolic; David C Lankin; Shao-Nong Chen; Sharla L Powell; Birgit Dietz; Judy L Bolton; Richard B van Breemen; Norman R Farnsworth; Guido F Pauli
Journal:  Phytochem Anal       Date:  2009 Mar-Apr       Impact factor: 3.373

9.  Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial.

Authors:  Stacie E Geller; Lee P Shulman; Richard B van Breemen; Suzanne Banuvar; Ying Zhou; Geena Epstein; Samad Hedayat; Dejan Nikolic; Elizabeth C Krause; Colleen E Piersen; Judy L Bolton; Guido F Pauli; Norman R Farnsworth
Journal:  Menopause       Date:  2009 Nov-Dec       Impact factor: 2.953

10.  Medical potential of plants used by the Q'eqchi Maya of Livingston, Guatemala for the treatment of women's health complaints.

Authors:  Joanna Michel; Reinel Eduardo Duarte; Judy L Bolton; Yue Huang; Armando Caceres; Mario Veliz; Djaja Doel Soejarto; Gail B Mahady
Journal:  J Ethnopharmacol       Date:  2007-08-06       Impact factor: 4.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.